Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Lachmann is active.

Publication


Featured researches published by Robert Lachmann.


European Respiratory Journal | 2001

Partial liquid ventilation improves lung function in ventilation-induced lung injury

G.F. Vazquez de Anda; Robert Lachmann; Serge Verbrugge; Diederik Gommers; Jack J. Haitsma; Burkhard Lachmann

Disturbances in lung function and lung mechanics are present after ventilation with high peak inspiratory pressures (PIP) and low levels of positive end-expiratory pressure (PEEP). Therefore, the authors investigated whether partial liquid ventilation can re-establish lung function after ventilation-induced lung injury. Adult rats were exposed to high PIP without PEEP for 20 min. Thereafter, the animals were randomly divided into five groups. The first group was killed immediately after randomization and used as an untreated control. The second group received only sham treatment and ventilation, and three groups received treatment with perfluorocarbon (10 mL x kg(-1), 20 mL x kg(-1), and 20 ml x kg(-1) plus an additional 5 mL x kg(-1) after 1 h). The four groups were maintained on mechanical ventilation for a further 2-h observation period. Blood gases, lung mechanics, total protein concentration, minimal surface tension, and small/large surfactant aggregates ratio were determined. The results show that in ventilation-induced lung injury, partial liquid ventilation with different amounts of perflubron improves gas exchange and pulmonary function, when compared to a group of animals treated with standard respiratory care. These effects have been observed despite the presence of a high intra-alveolar protein concentration, especially in those groups treated with 10 and 20 mL of perflubron. The data suggest that replacement of perfluorocarbon, lost over time, is crucial to maintain the constant effects of partial liquid ventilation.


European Respiratory Journal | 2005

Effect of ventilation strategy and surfactant on inflammation in experimental pneumonia

A.H. van Kaam; Rene Lutter; Robert Lachmann; Jack J. Haitsma; Egbert Herting; M. Snoek; A. P. M. C. De Jaegere; Joke Kok; Burkhard Lachmann

This study explored, the inflammatory response during experimental pneumonia in surfactant-depleted animals as a function of ventilation strategies and surfactant treatment. Following intratracheal instillation of Group B streptococci (GBS), surfactant-depleted piglets were treated with conventional (positive-end expiratory pressure (PEEP) of 5 cmH2O, tidal volume 7 mL·kg−1) or open lung ventilation. During the latter, collapsed alveoli were recruited by applying high peak inspiratory pressures for a short period of time, combined with high levels of PEEP and the smallest possible pressure amplitude. Subgroups in both ventilation arms also received exogenous surfactant. Conventionally ventilated healthy animals receiving GBS and surfactant-depleted animals receiving saline served as controls. In contrast with both control groups, surfactant-depleted animals challenged with GBS and conventional ventilation showed high levels of interleukin (IL)-8, tumour necrosis factor (TNF)-α and myeloperoxidase in bronchoalveolar lavage fluid after 5 h of ventilation. Open lung ventilation attenuated this inflammatory response, but exogenous surfactant did not. Systemic dissemination of the inflammatory response was minimal, as indicated by low serum levels of IL-8 and TNF-α. In conclusion, the current study indicates that the ventilation strategy, but not exogenous surfactant, is an important modulator of the inflammation during Group B streptococci pneumonia in mechanically ventilated surfactant-depleted animals.


Experimental Lung Research | 2004

Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model.

Robert Lachmann; A. H. L. C. van Kaam; Jack J. Haitsma; S. J. C. Verbrugge; F. Delreu; Burkhard Lachmann

Mechanical ventilation is known to induce bacterial translocation from the lung into the systemic circulation. This study determined the effect of immunoglobulin M (IgM)-enriched polyclonal immunoglobulins on bacteremia due to ventilation-induced translocation in an acute respiratory distress syndrome (ARDS) rat model with Klebsiella-induced pneumonia. After whole lung lavage, Sprague-Dawley rats intravenously received either a high dose or a low dose of an immunoglobulin preparation, or an albumin solution as control, followed by an intratracheal injection of a Klebsiella pneumoniae solution. Blood colony-forming units (CFUs) in the treatment groups were significantly lower during the 3-hour ventilation period compared to the control group. The authors conclude that IgM-enriched polyclonal immunoglobulins lead to a reduction of bacteria in blood of surfactant-deficient, ventilated rats infected with Klebsiella pneumoniae.


Clinical Physiology and Functional Imaging | 2006

Liver‐type fatty acid binding protein in serum and broncho‐alveolar lavage in a model of acute respiratory failure because of surfactant depletion – a possible marker for lung damage?

Robert Lachmann; S. Werchan; Christian Schachtrup; Jack J. Haitsma; Friedrich Spener; Burkhard Lachmann

Introduction  Liver‐type fatty acid binding proteins (L‐FABP) have been shown to be present in alveolar macrophages and type II pneumocytes of the lung. This study determined levels of L‐FABP in serum and broncho‐alveolar lavage (BAL) during experimental acute respiratory failure (ARF) to evaluate whether this molecule can serve as a marker for lung damage.


Journal of Heart and Lung Transplantation | 2012

Alveolar preservation with high inflation pressure and intermediate oxygen concentration reduces ischemia- reperfusion injury of the lung

Niels P. van der Kaaij; Jolanda Kluin; Robert Lachmann; Michael A. den Bakker; Bart N. Lambrecht; Burkhard Lachmann; Ron W. F. de Bruin; Ad J.J.C. Bogers

BACKGROUND This study investigated the optimal alveolar oxygen concentration and inflation pressure during ischemia that reduces lung ischemia-reperfusion injury (LIRI). METHODS Male Sprague-Dawley rats (n = 66) underwent 150 minutes of left lung ischemia by hilar clamping at an airway inflation pressure (P) of 5 or 30 cm H(2)O and an oxygen (O) concentration of 0%, 30%, or 100% (P(5)O(0), P(5)O(30), P(5)O(100), P(30)O(0), P(30)O(30) and P(30)O(100) groups). Lungs preserved with 0% oxygen were inflated with 100% nitrogen. Measurements of arterial blood gas values, pulmonary compliance, histology, flow cytometry of bronchoalveolar lavage fluid were performed on day 2 postoperatively. RESULTS Inflation with 30 cm H(2)O resulted in increased partial pressure of arterial oxygen (Pao(2)) and lung compliance, decreased diffuse alveolar damage, and less infiltration of CD4(+) and CD8(+) lymphocytes and major histocompatibility complex class II-positive (MHCII(+)) antigen-presenting cells (APCs) in the left lung on day 2 compared with clamping at an airway inflation pressure of 5 cm H(2)O. The 100% oxygen groups demonstrated a lower Pao(2) and a decreased pulmonary compliance than 30% oxygen groups. More CD8(+) lymphocytes and MHCII(+) APCs were found in the P(5)O(100) group than in the P(5)O(0) and P(5)O(30) groups. CONCLUSION Alveolar inflation with a pressure of 30 cm H(2)O and an oxygen concentration of 30% decreases the severity of LIRI. The protective effect is mainly due to hyperinflation and, to a lesser extent, through oxygen concentration.


Journal of Organ Dysfunction | 2006

Surfactant alterations and treatment of lung transplant ischemia-reperfusion injury

Niels P. van der Kaaij; Robert Lachmann; Ad J.J.C. Bogers; Burkhard Lachmann

This review addresses surfactant alterations and treatment in lung transplant ischemia–reperfusion injury. Lung ischemia–reperfusion injury damages the endogenous surfactant system as a result of the production of reactive oxygen species, proteolytic enzymes and (phospho)lipases. Surfactant is composed of phospholipids and proteins and its main function is to reduce the surface tension inside the alveolus. Impairment of surfactant will cause atelectasis, influx of serum proteins, pulmonary edema, decreased lung compliance and impaired gas exchange. Surfactant therapy restores the quantity and composition of surfactant and reduces the inhibitory effect of serum proteins; other effects are that it serves as an antioxidant and anti-inflammatory agent. Pretreatment may be more beneficial than treatment after the development of lung ischemia–reperfusion injury. However, the cost of surfactant must be weighed against the clinical outcome.


Acta Anaesthesiologica Scandinavica | 2006

Small-dose perfluorocarbon reduces the recruitment pressure needed to open surfactant-deficient atelectatic lungs

Robert Jan Houmes; Robert Lachmann; Jack J. Haitsma; Burkhard Lachmann

Background:  This study was undertaken to investigate the effect of a small dose of perfluorocarbon on the recruitment pressure needed to open atelectatic lung areas.


American Journal of Respiratory and Critical Care Medicine | 2004

Reducing Atelectasis Attenuates Bacterial Growth and Translocation in Experimental Pneumonia

Anton H. van Kaam; Robert Lachmann; Egbert Herting; Anne De Jaegere; Freek van Iwaarden; L. Arnold Noorduyn; Joke H. Kok; Jack J. Haitsma; Burkhard Lachmann


American Journal of Respiratory and Critical Care Medicine | 2004

Phosphoinositide 3-OH Kinase Inhibition Prevents Ventilation-induced Lung Cell Activation

Ulrike Uhlig; Heinz Fehrenbach; Robert Lachmann; Torsten Goldmann; Burkhard Lachmann; Ekkehard Vollmer; Stefan Uhlig


Intensive Care Medicine | 2007

High positive end-expiratory pressure levels promote bacterial translocation in experimental pneumonia

Robert Lachmann; Anton H. van Kaam; Jack J. Haitsma; Burkhard Lachmann

Collaboration


Dive into the Robert Lachmann's collaboration.

Top Co-Authors

Avatar

Burkhard Lachmann

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Egbert Herting

University of Göttingen

View shared research outputs
Top Co-Authors

Avatar

Ad J.J.C. Bogers

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Anton H. van Kaam

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Serge Verbrugge

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Anne De Jaegere

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Diederik Gommers

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

G.F. Vazquez de Anda

Erasmus University Rotterdam

View shared research outputs
Researchain Logo
Decentralizing Knowledge